How Common Are Endolymphatic Hydrops and Ménière's Disease?
At a Glance
Clinically diagnosed Ménière’s disease affects about 0.05% to 0.2% of adults, but endolymphatic hydrops can also appear on MRI without symptoms. An MRI finding alone cannot diagnose Ménière’s disease; symptom history and hearing tests are essential.
In this answer
4 sections
Key takeaway: A scan showing fluid buildup (hydrops) is not the same as having symptomatic Ménière’s disease. Furthermore, finding hydrops in your opposite, symptom-free ear does not necessarily mean that ear will eventually develop the disease [1][2].
Clinically diagnosed Ménière’s disease is relatively uncommon. Published population studies estimate it affects roughly 0.05% to 0.2% of adults (about 50 to 200 out of every 100,000 people) [3]. However, this is an approximation, and exact estimates vary depending on the country, the population studied, and the specific diagnostic definitions used [3][4]. Statistical estimates of prevalence fluctuate in part because medical guidelines have changed over time, such as the shift from older 1995 frameworks to current criteria [5][4].
Ménière’s Disease vs. MRI-Detected Hydrops
Endolymphatic hydrops refers to an abnormal expansion of fluid in the inner ear spaces (not the middle ear) [6]. While it is frequently associated with Ménière’s disease, the two are not the same thing.
Ménière’s disease is diagnosed based on clinical consensus criteria—currently, the 2015 international criteria formulated by the Bárány Society [7]. These criteria classify the disease as either “definite” or “probable” [7]. A “definite” diagnosis requires a specific history of episodic vertigo and fluctuating ear symptoms, plus objective proof of low- to medium-frequency sensorineural hearing loss on a clinical hearing test (audiometry) [8][7].
Endolymphatic hydrops is an associated finding that may contribute to symptoms, but it is neither necessary nor sufficient to make a diagnosis [6][1]. The distinction is important for several reasons:
- Hydrops is common in people without Ménière’s disease: While specialized inner-ear MRI scans detect hydrops in about 82% of patients with definite or probable Ménière’s disease, they also find it in people with other conditions, like vestibular migraine [1].
- Hydrops can be completely asymptomatic: Specialized MRI studies have found incidental hydrops in 7% of healthy volunteers in one specific cohort [9], while a broader literature review found an average rate of 31% among healthy control subjects [1].
- Imaging findings can change: Sometimes, incidental fluid buildup discovered on a scan will simply disappear over time [9]. However, this apparent resolution on a scan does not guarantee that the finding was harmless, nor does it mean an established clinical case of Ménière’s disease is cured [9].
Finding hydrops on a dedicated scan can support a doctor’s diagnosis, but it cannot confirm it and does not replace a careful clinical history and audiogram [6].
Who Is Most Likely to Develop It?
Anyone can develop Ménière’s disease [10]. Age and sex patterns merely describe groups; they cannot be used to confirm or rule out a diagnosis for you as an individual [10].
- Age: The condition is predominantly diagnosed in middle to later adulthood [10]. Extensive population registries show the average age at diagnosis is typically between 55 and 60 years old [10][11][12].
- Sex: Women form a modest majority of cases [10]. In large registry studies, women make up about 54% to 65% of those diagnosed [10][11].
Does It Affect One Ear or Both?
Ménière’s disease usually starts in just one ear [13]. Bilateral Ménière’s disease (experiencing clinical symptoms in both ears) is reported in roughly 5% to 15% of patients in specific clinical cohorts [13][14][15]. These numbers can vary significantly based on how long patients are followed [13].
When clinical symptoms do develop in both ears, they usually happen sequentially rather than at the same time [16]. One clinical study found a median time of 7 years before the second ear developed symptoms, though this is a cohort average, not a specific prediction for your individual risk [16].
It is understandable to worry about the health of your other ear. Interestingly, in patients with one-sided Ménière’s disease, MRI scans sometimes reveal endolymphatic hydrops in their opposite, “healthy” ear—occurring in about 23% to 24% of these asymptomatic ears [2]. But just as in healthy populations, this imaging finding alone does not automatically mean you will develop clinical symptoms in that second ear [2][17].
Diagnostic Monitoring
Because symptoms overlap with other conditions, a diagnosis may be revised over time as the disease evolves [7]. Monitoring your condition usually involves baseline and follow-up audiograms as directed by your clinician, and carefully tracking which ear is experiencing symptoms [7].
Safety Note: Sudden hearing loss, new neurologic symptoms, or severe continuous vertigo can sometimes mimic Ménière’s disease but require prompt medical assessment to rule out other causes [7].
Common questions in this guide
How common is clinically diagnosed Ménière’s disease?
Does endolymphatic hydrops on an MRI mean I have Ménière’s disease?
Can someone have endolymphatic hydrops without symptoms?
How often does Ménière’s disease affect both ears?
Does hydrops in my symptom-free ear mean I will develop Ménière’s disease there?
Who is most likely to be diagnosed with Ménière’s disease?
How is Ménière’s disease monitored over time?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Would a hearing test (audiogram) be needed to support a Ménière's disease finding?
Monitoring over time
How would follow-up audiograms track my condition over time?
Symptoms to report
Which symptoms would mean I need prompt assessment to rule out other causes?
Related questions
Show more
Get notified when new evidence is published on endolymphatic hydrops.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
The "hype" of hydrops in classifying vestibular disorders: a narrative review.
van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.
Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.
PMID: 33201310 - 2
Endolymphatic hydrops in contralateral ear of patients with unilateral Meniere's disease.
Wang J, Huang Y, Zhao P, et al.
Acta oto-laryngologica 2026; (146(4)):500-507 doi:10.1080/00016489.2026.2613137.
PMID: 41636232 - 3
Epidemiological and clinical differences in Meniere disease across European and East Asian populations.
Lopez-Escamez JA, Xu M, Zhang Q, Tsang BK
The Journal of international medical research 2026; (54(8)):3000605261473157 doi:10.1177/03000605261473157.
PMID: 42545183 - 4
What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.
Gürkov R, Pyykö I, Zou J, Kentala E
Journal of neurology 2016; (263 Suppl 1()):S71-81 doi:10.1007/s00415-015-7930-1.
PMID: 27083887 - 5
2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Ménière's Disease.
Goebel JA
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2016; (154(3)):403-4 doi:10.1177/0194599816628524.
PMID: 26884364 - 6
Magnetic resonance imaging and Ménière's disease-unavoidable alliance.
Sousa R, Raposo F, Guerreiro C, et al.
Neuroradiology 2021; (63(11)):1749-1763 doi:10.1007/s00234-021-02744-5.
PMID: 34142211 - 7
On the classification of hydropic ear disease (Menière's disease).
Gürkov R, Hornibrook J
HNO 2018; (66(6)):455-463 doi:10.1007/s00106-018-0488-3.
PMID: 29500497 - 8
Menière and Friends: Imaging and Classification of Hydropic Ear Disease.
Gürkov R
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(10)):e539-e544 doi:10.1097/MAO.0000000000001479.
PMID: 29135874 - 9
Prognosis of asymptomatic endolymphatic hydrops in healthy volunteers: A five-year cohort study.
Kimura T, Kitahara T, Okayasu T, et al.
Laryngoscope investigative otolaryngology 2024; (9(6)):e70026 doi:10.1002/lio2.70026.
PMID: 39525523 - 10
Population-Based Study on the Epidemiology of Ménière's Disease.
Bruderer SG, Bodmer D, Stohler NA, et al.
Audiology & neuro-otology 2017; (22(2)):74-82 doi:10.1159/000475875.
PMID: 28723686 - 11
Epidemiology, Health Care Utilization, and Employment Status in Ménière Disease: A Danish Register-based Cohort Study From 1995 to 2019.
Grønlund C, Devantier L, Karlberg M, Djurhuus BD
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2025; (46(10)):e511-e518 doi:10.1097/MAO.0000000000004631.
PMID: 41145394 - 12
Long-term economic and welfare consequences of Ménière's disease: a Danish nationwide matched cohort study, 2002-2016.
Grønlund C, Möller S, Christensen HC, et al.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(7)):4287-4296 doi:10.1007/s00405-026-10140-z.
PMID: 42086989 - 13
Characteristics of clinical details and endolymphatic hydrops in unilateral and bilateral Ménière's disease in a single Asian group.
Shi S, Li W, Wang D, et al.
Frontiers in neurology 2022; (13()):964217 doi:10.3389/fneur.2022.964217.
PMID: 36176561 - 14
An Update on the Epidemiology and Clinicodemographic Features of Meniere's Disease.
De Ravin E, Quimby AE, Bartellas M, et al.
The Laryngoscope 2024; (134(7)):3310-3315 doi:10.1002/lary.31282.
PMID: 38238895 - 15
Clinical Characteristics of Bilateral Meniere's Disease in a Single Asian Ethnic Group.
Suh MJ, Jeong J, Kim HJ, et al.
The Laryngoscope 2019; (129(5)):1191-1196 doi:10.1002/lary.27423.
PMID: 30284277 - 16
Bilateral Ménière's disease according to its form of debut: synchronous and metachronous disease.
Pérez-Carbonell T, Orts-Alborch M, Pla-Gil I, et al.
The Journal of laryngology and otology 2023; (137(7)):782-788 doi:10.1017/S0022215122002262.
PMID: 36200516 - 17
Clinical Features and Endolymphatic Hydrops in Patients With MRI Evidence of Hydrops.
Shi S, Guo P, Li W, Wang W
The Annals of otology, rhinology, and laryngology 2019; (128(4)):286-292 doi:10.1177/0003489418819551.
PMID: 30556402
This page explains population estimates and the difference between MRI-detected hydrops and Ménière's disease for informational purposes only and does not constitute medical advice. An ENT specialist or audiologist should interpret your symptoms, hearing tests, and scans.